Tolerance of Kidney and Islet Transplants via the Mixed Chimerism Approach
$643,646U19FY2012AINIH
Massachusetts General Hospital, Boston MA
Investigators
Linked publications & trials
Paper 31397805Paper 30300283Paper 30113996Paper 29505692Paper 29300231Paper 29288556Paper 29286578Paper 29189413Paper 29187852Paper 29175110Paper 28444814Paper 28369830Paper 28071653Paper 27501203Paper 27446989Paper 27376692Paper 26517761Paper 26337731Paper 26190648Paper 25904524Paper 25806407Paper 25563992Paper 25535285Paper 25394378Paper 25240733Paper 24933456Paper 24913821Paper 24903438Paper 24462799Paper 24165326Paper 23883972Paper 23865775Paper 23838644Paper 23656665Paper 22960786Paper 22850181Paper 22690270Paper 22682297Paper 22586034Paper 22537262Paper 22510337Paper 22450441Paper 22449945Paper 22390179Paper 22300494Paper 22297669Paper 22231130Paper 22179403Paper 22114174Paper 22070565Paper 22053723Paper 22051115Paper 21957140Paper 21666482Paper 21601837Paper 20642676Paper 20486921Paper 18216355
Abstract
PROJECT SUMMARY (See instructions): Induction of specific immunologic tolerance is an ultimate goal of organ transplantation. Based on the conditioning regimen developed in our laboratory by decades-long research in nonhuman primates (NHP), we have now successfully achieved renal allograft tolerance in HLA mismatched human kidney transplant recipients via the mixed chimerism approach. However, limitations of this approach have been its inapplicability for deceased donor transplantation and the inability to induce tolerance of non-renal organs/cells. To extend this approach to deceased donor transplantation, we recently developed a novel strategy of
View original record on NIH RePORTER →